Angiosarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2026-02-13
Clinical Trial Update: Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma [Phase 1]
A Phase I trial of TH1 dendritic cell immunotherapy for angiosarcoma has been withdrawn.